Opioid Peptide–expressing Leukocytes
Open Access
- 1 August 2001
- journal article
- pain medicine
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 95 (2) , 500-508
- https://doi.org/10.1097/00000542-200108000-00036
Abstract
Background: Inflammatory pain can be effectively controlled by an interaction of opioid receptors on peripheral sensory nerve terminals with opioid peptides released from immune cells upon stressful stimulation. To define the source of opioid peptide production, we sought to identify and quantify populations of opioid-containing cells during the course of Freund's complete adjuvant-induced hind paw inflammation in the rat. In parallel, we examined the development of stress-induced local analgesia in the paw. Methods: At 2, 6, and 96 h after Freund's complete adjuvant inoculation, cells were characterized by flow cytometry using a monoclonal pan-opioid antibody (3E7) and antibodies against cell surface antigens and by immunohistochemistry using a polyclonal antibody to beta-endorphin. After magnetic cell sorting, the beta-endorphin content was quantified by radioimmunoassay. Pain responses before and after cold water swim stress were evaluated by paw pressure thresholds. Results: In early inflammation, 66% of opioid peptide-producing (3E7+) leukocytes were HIS48+ granulocytes. In contrast, at later stages (96 h), the majority of 3E7+ immune cells were ED1+ monocytes or macrophages (73%). During the 4 days after Freund's complete adjuvant inoculation, the number of 3E7+ cells increased 5.6-fold (P < 0.001, Kruskal-Wallis test) and the beta-endorphin content in the paw multiplied 3.9-fold (P < 0.05, Kruskal-Wallis test). In parallel, cold water swim stress-induced analgesia increased by 160% (P < 0.01, analysis of variance). Conclusions: The degree of endogenous pain inhibition is proportional to the number of opioid peptide-producing cells, and distinct leukocyte lineages contribute to this function at different stages of inflammation. These mechanisms may be important for understanding pain in immunosuppressed states such as cancer, diabetes, or AIDS and for the design of novel therapeutic strategies in inflammatory diseases.Keywords
This publication has 15 references indexed in Scilit:
- Pain control in inflammation governed by selectinsNature Medicine, 1998
- Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytesJournal of Neuroimmunology, 1997
- Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats.Journal of Clinical Investigation, 1997
- Local analgesic effect of endogenous opioid peptidesThe Lancet, 1993
- Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissueNeuroscience, 1993
- Differential posttranslational processing of proenkephalin in rat bone marrow and spleen mononuclear cells: evidence for synenkephalin cleavageEndocrinology, 1993
- Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociceptionNeuroscience, 1992
- Differential processing of proenkephalin-A by human peripheral blood monocytes and T lymphocytes.Journal of Clinical Investigation, 1991
- Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.Proceedings of the National Academy of Sciences, 1990
- Binding Characteristics of a Monoclonal β‐Endorphin Antibody Recognizing the N‐Terminus of Opioid PeptidesJournal of Neurochemistry, 1983